Wells Fargo’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $361M | Buy |
5,946,447
+7,244
| +0.1% | +$422K | 0.07% | 250 |
|
|
2025
Q4 | $320M | Buy |
5,939,203
+398,555
| +7% | +$19.2M | 0.06% | 273 |
|
|
2025
Q3 | $250M | Buy |
5,540,648
+194,955
| +4% | +$9.1M | 0.05% | 323 |
|
|
2025
Q2 | $247M | Sell |
5,345,693
-1,502,474
| -22% | -$73.8M | 0.05% | 308 |
|
|
2025
Q1 | $418M | Buy |
6,848,167
+143,948
| +2% | +$8.39M | 0.09% | 198 |
|
|
2024
Q4 | $379M | Buy |
6,704,219
+357,487
| +6% | +$20M | 0.09% | 207 |
|
|
2024
Q3 | $328M | Sell |
6,346,732
-207,557
| -3% | -$9.74M | 0.07% | 231 |
|
|
2024
Q2 | $272M | Sell |
6,554,289
-2,858,186
| -30% | -$128M | 0.07% | 252 |
|
|
2024
Q1 | $510M | Buy |
9,412,475
+1,697,862
| +22% | +$86.5M | 0.12% | 159 |
|
|
2023
Q4 | $396M | Sell |
7,714,613
-694,611
| -8% | -$36.5M | 0.1% | 188 |
|
|
2023
Q3 | $488M | Sell |
8,409,224
-938,809
| -10% | -$57.5M | 0.14% | 147 |
|
|
2023
Q2 | $598M | Buy |
9,348,033
+2,716,162
| +41% | +$182M | 0.16% | 133 |
|
|
2023
Q1 | $460M | Buy |
6,631,871
+329,911
| +5% | +$23.3M | 0.13% | 158 |
|
|
2022
Q4 | $453M | Sell |
6,301,960
-227,968
| -3% | -$17.2M | 0.14% | 150 |
|
|
2022
Q3 | $464M | Sell |
6,529,928
-305,989
| -4% | -$22.2M | 0.15% | 141 |
|
|
2022
Q2 | $526M | Sell |
6,835,917
-1,165,197
| -15% | -$88.7M | 0.16% | 136 |
|
|
2022
Q1 | $584M | Buy |
8,001,114
+178,932
| +2% | +$12M | 0.15% | 140 |
|
|
2021
Q4 | $488M | Sell |
7,822,182
-2,162,868
| -22% | -$127M | 0.12% | 168 |
|
|
2021
Q3 | $591M | Sell |
9,985,050
-622,003
| -6% | -$41M | 0.13% | 154 |
|
|
2021
Q2 | $709M | Sell |
10,607,053
-561,819
| -5% | -$36.6M | 0.16% | 140 |
|
|
2021
Q1 | $705M | Sell |
11,168,872
-1,081,686
| -9% | -$67.3M | 0.16% | 136 |
|
|
2020
Q4 | $760M | Buy |
12,250,558
+833,884
| +7% | +$51.3M | 0.18% | 123 |
|
|
2020
Q3 | $688M | Sell |
11,416,674
-427,658
| -4% | -$25.7M | 0.19% | 118 |
|
|
2020
Q2 | $696M | Buy |
11,844,332
+1,032,395
| +10% | +$61.8M | 0.2% | 109 |
|
|
2020
Q1 | $603M | Sell |
10,811,937
-38,294
| -0.4% | -$2.34M | 0.21% | 107 |
|
|
2019
Q4 | $696M | Buy |
10,850,231
+2,181,324
| +25% | +$125M | 0.19% | 116 |
|
|
2019
Q3 | $440M | Buy |
8,668,907
+945,825
| +12% | +$44.5M | 0.12% | 166 |
|
|
2019
Q2 | $350M | Buy |
7,723,082
+539,626
| +8% | +$25.1M | 0.1% | 195 |
|
|
2019
Q1 | $343M | Sell |
7,183,456
-108,457
| -1% | -$5.4M | 0.1% | 192 |
|
|
2018
Q4 | $379M | Sell |
7,291,913
-37,430
| -0.5% | -$2.01M | 0.13% | 159 |
|
|
2018
Q3 | $455M | Buy |
7,329,343
+99,851
| +1% | +$5.93M | 0.13% | 161 |
|
|
2018
Q2 | $400M | Sell |
7,229,492
-1,048,388
| -13% | -$56.6M | 0.12% | 172 |
|
|
2018
Q1 | $524M | Sell |
8,277,880
-927,827
| -10% | -$59.7M | 0.16% | 136 |
|
|
2017
Q4 | $564M | Buy |
9,205,707
+900,280
| +11% | +$56.3M | 0.16% | 136 |
|
|
2017
Q3 | $529M | Sell |
8,305,427
-401,697
| -5% | -$23.5M | 0.16% | 139 |
|
|
2017
Q2 | $485M | Buy |
8,707,124
+615,966
| +8% | +$33.5M | 0.16% | 144 |
|
|
2017
Q1 | $440M | Sell |
8,091,158
-798,165
| -9% | -$43.8M | 0.14% | 155 |
|
|
2016
Q4 | $519M | Buy |
8,889,323
+983,108
| +12% | +$53.7M | 0.18% | 126 |
|
|
2016
Q3 | $426M | Sell |
7,906,215
-6,701,008
| -46% | -$430M | 0.16% | 143 |
|
|
2016
Q2 | $1.07B | Buy |
14,607,223
+104,876
| +0.7% | +$7.41M | 0.42% | 40 |
|
|
2016
Q1 | $926M | Sell |
14,502,347
-422,432
| -3% | -$26.6M | 0.37% | 51 |
|
|
2015
Q4 | $1.03B | Buy |
14,924,779
+4,826,416
| +48% | +$319M | 0.41% | 38 |
|
|
2015
Q3 | $598M | Buy |
10,098,363
+238,204
| +2% | +$15.1M | 0.25% | 84 |
|
|
2015
Q2 | $656M | Buy |
9,860,159
+560,649
| +6% | +$36.9M | 0.25% | 82 |
|
|
2015
Q1 | $600M | Sell |
9,299,510
-425,863
| -4% | -$26.7M | 0.23% | 95 |
|
|
2014
Q4 | $574M | Buy |
9,725,373
+484,163
| +5% | +$27.3M | 0.23% | 101 |
|
|
2014
Q3 | $473M | Sell |
9,241,210
-575,914
| -6% | -$28.8M | 0.2% | 119 |
|
|
2014
Q2 | $476M | Sell |
9,817,124
-961,223
| -9% | -$47.4M | 0.2% | 117 |
|
|
2014
Q1 | $560M | Buy |
10,778,347
+653,544
| +6% | +$34.8M | 0.24% | 93 |
|
|
2013
Q4 | $538M | Buy |
10,124,803
+2,001,594
| +25% | +$102M | 0.23% | 97 |
|
|
2013
Q3 | $376M | Sell |
8,123,209
-344,433
| -4% | -$15.1M | 0.18% | 149 |
|
|
2013
Q2 | $378M | Buy |
+8,467,642
| New | +$368M | 0.2% | 125 |
|
Other funds holding BMY
VCM
VPM
Wells Fargo's BMY Position: Q1 2026 in Review
Wells Fargo increased its Bristol-Myers Squibb (BMY) stake by 0.12% in Q1 2026, buying an estimated $422K and bringing the position to 5,946,447 shares worth $361M. The position accounts for 0.07% of the portfolio, ranked #250.
Wells Fargo first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.07B in Q2 2016. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Wells Fargo held 5,946,447 shares of Bristol-Myers Squibb worth $361M as of Q1 2026.
- Wells Fargo bought 7,244 Bristol-Myers Squibb shares in Q1 2026, an estimated $422K.
- Bristol-Myers Squibb made up 0.07% of Wells Fargo's portfolio in Q1 2026, its #250 holding.
- Wells Fargo first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Bristol-Myers Squibb position peaked at $1.07B in Q2 2016.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.